摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

O5,O6-isopropylidene-D-gulonic acid-4-lactone | 67321-94-2

中文名称
——
中文别名
——
英文名称
O5,O6-isopropylidene-D-gulonic acid-4-lactone
英文别名
O5,O6-Isopropyliden-D-gulonsaeure-4-lacton;5,6-O-isopropylidene-D-gulonic acid γ-lactone;5,6-O-Isopropylidene-D-gulonic acid gamma-lactone;(3R,4S,5R)-5-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-3,4-dihydroxyoxolan-2-one
<i>O</i><sup>5</sup>,<i>O</i><sup>6</sup>-isopropylidene-D-gulonic acid-4-lactone化学式
CAS
67321-94-2
化学式
C9H14O6
mdl
——
分子量
218.207
InChiKey
JNTPPVKRHGNFKM-UCROKIRRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    166-170 °C
  • 沸点:
    355.7±42.0 °C(Predicted)
  • 密度:
    1.425±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -1
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.89
  • 拓扑面积:
    85.2
  • 氢给体数:
    2
  • 氢受体数:
    6

SDS

SDS:be74844c08dbf159c357ed0d8fe6b61b
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • SUBSTITUTED NUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS
    申请人:Pfizer Inc.
    公开号:US20160244475A1
    公开(公告)日:2016-08-25
    Compounds of the general formula (I): processes for the preparation of these compounds, compositions containing these compounds, and the uses of these compounds.
    通式(I)的化合物: 制备这些化合物的方法,含有这些化合物的组合物,以及这些化合物的用途。
  • [EN] METHODS FOR THE PREPARATION OF (3R,3aS,6aR) HEXAHYDRO-FURO[2,3-b]FURAN-3-OL<br/>[FR] PROCEDES DE PREPARATION DE (3R,3AS,6AR)HEXAHYDRO-FURO[2,3-B]FURAN-3-OL
    申请人:TIBOTEC PHARM LTD
    公开号:WO2005095410A1
    公开(公告)日:2005-10-13
    The present invention relates to methods for the preparation of diastereomerically pure (3R,3aS,6aR) hexahydro-furo[2,3-b]furan-3-ol (6) as well as a novel intermediate, (3aR,4S,6aS) 4-methoxy-tetrahydro-furo[3,4-b]furan-2-one (4) for use in said methods. More in particular the invention relates to a stereoselective method for the preparation of diastereomerically pure (3R,3aS,6aR) hexahydro-furo[2,3-b]furan-3-ol, as well as methods for the crystallization of (3aR,4S,6aS) 4-methoxy-tetrahydro-furo[3,4-b]furan- 2-one and for the epimerization of (3aR,4R,6aS) 4-methoxy-tetrahydro-furo[3,4-b]-furan-2-one to (3aR,4S,6aS) 4-methoxy-tetrahydro-furo[3,4-b]furan-2-one.
    本发明涉及制备对映异构体纯度高的(3R,3aS,6aR)六氢呋喃[2,3-b]呋喃-3-醇(6)的方法,以及用于该方法的新型中间体(3aR,4S,6aS) 4-甲氧基四氢呋喃[3,4-b]呋喃-2-酮(4)。更具体地说,本发明涉及一种立体选择性的制备对映异构体纯度高的(3R,3aS,6aR)六氢呋喃[2,3-b]呋喃-3-醇的方法,以及用于(3aR,4S,6aS) 4-甲氧基四氢呋喃[3,4-b]呋喃-2-酮的结晶方法和(3aR,4R,6aS) 4-甲氧基四氢呋喃[3,4-b]-呋喃-2-酮的外消旋化为(3aR,4S,6aS) 4-甲氧基四氢呋喃[3,4-b]呋喃-2-酮的方法。
  • [EN] METHOD FOR THE PREPARATION OF HEXAHYDRO-FURO[2,3-B]FURAN-3-OL<br/>[FR] PROCEDE DE PREPARATION D'UN HEXAHYDRO-FURO[2,3-B]FURANE-3-OL
    申请人:TIBOTEC PHARM LTD
    公开号:WO2003022853A1
    公开(公告)日:2003-03-20
    The present invention relates to a method for the preparation of hexahydro-furo[2,3-b]furan-3-ol as well as novel intermediates for use in said method. More in particular the invention relates to a stereoselective method for the preparation of hexahydro-furo[2,3-b]furan-3-ol, and to a method amenable to industrial scaling up.
    本发明涉及一种制备六氢呋喃[2,3-b]呋喃-3-醇的方法,以及用于该方法的新型中间体。更具体地,本发明涉及一种立体选择性制备六氢呋喃[2,3-b]呋喃-3-醇的方法,以及一种适用于工业放大的方法。
  • Method for the preparation of hexahydro-furo-[2,3-b]furan-3-ol
    申请人:——
    公开号:US20040249175A1
    公开(公告)日:2004-12-09
    The present invention relates to a method for the preparation of hexahydro-furo[2,3-b]furan-3-ol as well as novel intermediates for use in said method. More in particular the invention relates to a stereoselective method for the preparation of hexahydro-furo[2,3-b]furan-3-ol, and to a method amenable to industrial scaling up.
    本发明涉及一种制备六氢呋喃[2,3-b]呋喃-3-醇及其在该方法中使用的新型中间体的方法。更具体地,本发明涉及一种立体选择性制备六氢呋喃[2,3-b]呋喃-3-醇的方法,以及一种适用于工业放大的方法。
  • METHODS FOR THE PREPARATION OF (3R,3aS,6aR) HEXAHYDRO-FURO[2,3-b]FURAN-3-OL
    申请人:Quaedflieg Mario Peter Jan Leonard
    公开号:US20070208184A1
    公开(公告)日:2007-09-06
    The present invention relates to methods for the preparation of diastereomerically pure (3R,3aS,6aR)hexahydro-furo[2,3-b]furan-3-ol as well as a novel intermediate, (3aR,4S,6aS)4-methoxy-tetrahydro-furo[3,4-b]furan-2-one for use in said methods. More in particular the invention relates to a stereoselective method for the preparation of diastereomerically pure (3R,3aS,6aR)hexahydro-furo[2,3-b]furan-3-ol, as well as methods for the crystallization of (3aR,4S,6aS)4-methoxy-tetrahydro-furo[3,4-b]furan-2-one and for the epimerization of (3aR,4R,6aS)4-methoxy-tetrahydro-furo[3,4-b]-furan-2-one to (3aR,4S,6aS)4-methoxy-tetrahydro-furo[3,4-b]furan-2-one.
    本发明涉及制备对映异构体纯度高的(3R,3aS,6aR)六氢呋喃[2,3-b]呋喃-3-醇的方法,以及一种新的中间体(3aR,4S,6aS)4-甲氧基四氢呋喃[3,4-b]呋喃-2-酮,用于上述方法。更具体地说,本发明涉及一种立体选择性方法,用于制备对映异构体纯度高的(3R,3aS,6aR)六氢呋喃[2,3-b]呋喃-3-醇,以及用于结晶(3aR,4S,6aS)4-甲氧基四氢呋喃[3,4-b]呋喃-2-酮和对(3aR,4R,6aS)4-甲氧基四氢呋喃[3,4-b]呋喃-2-酮进行外消旋反应以得到(3aR,4S,6aS)4-甲氧基四氢呋喃[3,4-b]呋喃-2-酮的方法。
查看更多